However, decreased expression of C3, C1S, complement C1r (C1R), and plasminogen activator, urokinase receptor (PLAUR) were detected in CS AF-treated IECs, which indicates that the complement and coagulation cascades have not developed completely. The gene discussed is C3; the disease is atrial fibrillation.